Norway· NO-ID_A8641585-B464-40AA-BA48-F86C64F3C208

Kineret

A anakinra product containing anakinra, registered in Norway by Swedish Orphan Biovitrum International AB. The same ATC class is registered in 13 of our 19 countries.

ATC L04AC03

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedKineretATCL04AC03REGISTER NO.NO-ID_A8641585-B464-4…PACKS LISTED5CHECKEDSeptember 25, 2026

Where it is registered

Anakinra is registered in 13 of 19 countries.

Countries holding a registration under ATC L04AC03 (anakinra), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 8 of them publish a price we can compare per daily dose

Anakinra · ATC L04AC03

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Anakinra
Manufacturer
Swedish Orphan Biovitrum International AB
Country
Norway (NO)
ATC code
L04AC03
ATC class
Anakinra
Defined daily dose
0.1 g, P
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 5

2 priced
  • no_merkevare_id
    ID_A8641585-B464-40AA-BA48-F86C64F3C208
  • no_varenummer
    373254
    28 x 0.67
    NOK 11392.4
  • no_varenummer
    418642
    7 x 0.67
    NOK 2875.3
  • gtin
    7350031440317
  • gtin
    7350031442113

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

375 interactions on record for anakinra.

Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Anakinra · interactions on record

375 records

  • 31 severe
  • 337 moderate
  • 7 minor

Most severe, free to view

  • CladribineL01BB04severe
  • PrednisoloneA07EA01moderate
  • HydrocortisoneA07EA02moderate
  • PrednisoneA07EA03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9ab83a0e-c736-4cfb-8d5c-be583e19c882
GET /v1/drugs/9ab83a0e-c736-4cfb-8d5c-be583e19c882?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Injeksjonsvæske, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Anakinra",
  "merkevare_id": "ID_A8641585-B464-40AA-BA48-F86C64F3C208",
  "name_form_strength": "Kineret inj, oppl 100 mg/sprøyte",
  "prescription_group": "C"
}

See everything about anakinra.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.